HK1056882A1 - Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof. - Google Patents

Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof.

Info

Publication number
HK1056882A1
HK1056882A1 HK03109287A HK03109287A HK1056882A1 HK 1056882 A1 HK1056882 A1 HK 1056882A1 HK 03109287 A HK03109287 A HK 03109287A HK 03109287 A HK03109287 A HK 03109287A HK 1056882 A1 HK1056882 A1 HK 1056882A1
Authority
HK
Hong Kong
Prior art keywords
synthesis
therapeutic applications
molecules containing
peroxide derivative
dual molecules
Prior art date
Application number
HK03109287A
Other languages
English (en)
Inventor
Bernard Meunier
Anne Robert
Odile Dechy-Cabaret
Francoise Benoit-Vical
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of HK1056882A1 publication Critical patent/HK1056882A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D323/00Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C07D323/04Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK03109287A 2000-04-06 2004-01-06 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof. HK1056882A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0004422A FR2807433B1 (fr) 2000-04-06 2000-04-06 Molecules duales contenant un derives peroxydique, leur synthese et leurs applications therapeutiques
PCT/FR2001/001013 WO2001077105A1 (fr) 2000-04-06 2001-04-04 Molecules duales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques

Publications (1)

Publication Number Publication Date
HK1056882A1 true HK1056882A1 (en) 2004-03-05

Family

ID=8848956

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03109287A HK1056882A1 (en) 2000-04-06 2004-01-06 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof.

Country Status (28)

Country Link
US (2) US6949569B2 (no)
EP (1) EP1268470B1 (no)
JP (1) JP2004521855A (no)
KR (1) KR100832047B1 (no)
CN (1) CN1193028C (no)
AP (1) AP1399A (no)
AR (1) AR041773A1 (no)
AT (1) ATE387441T1 (no)
AU (2) AU4846301A (no)
BR (1) BR0109885A (no)
CA (1) CA2405076C (no)
CY (1) CY1108071T1 (no)
DE (1) DE60132981T2 (no)
DK (1) DK1268470T3 (no)
ES (1) ES2302727T3 (no)
FR (1) FR2807433B1 (no)
HK (1) HK1056882A1 (no)
HU (1) HUP0300428A2 (no)
IL (2) IL151918A0 (no)
IS (1) IS6579A (no)
MX (1) MXPA02009856A (no)
MY (1) MY128443A (no)
NO (1) NO329526B1 (no)
NZ (1) NZ521774A (no)
OA (1) OA13294A (no)
PT (1) PT1268470E (no)
WO (1) WO2001077105A1 (no)
ZA (1) ZA200207851B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862304A1 (fr) * 2003-11-14 2005-05-20 Centre Nat Rech Scient Molecules duales racemiques ou achirales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques
TW200728315A (en) * 2005-12-06 2007-08-01 Nippon Chemical Ind Phosphorus transition-metal complex, method of producing the same, and anticancer agent forming the same
FR2902100A1 (fr) * 2006-06-13 2007-12-14 Sanofi Aventis Sa Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique
FR2924343A1 (fr) * 2007-12-04 2009-06-05 Palumed Sa Nouvelles utilisations therapeutiques de molecules duales contenant un derive peroxydique.
US9018409B2 (en) * 2010-10-27 2015-04-28 Meurice R&D Asbl Process for functionalization of unsaturated compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69614149T2 (de) * 1995-11-16 2002-03-14 F. Hoffmann-La Roche Ag, Basel Chinolinderivate als antimalariamittel

Also Published As

Publication number Publication date
AP1399A (en) 2005-04-27
IL151918A (en) 2010-04-29
WO2001077105A1 (fr) 2001-10-18
IS6579A (is) 2002-10-03
BR0109885A (pt) 2003-06-03
US7566710B2 (en) 2009-07-28
IL151918A0 (en) 2003-04-10
CN1193028C (zh) 2005-03-16
NZ521774A (en) 2005-10-28
EP1268470A1 (fr) 2003-01-02
CA2405076C (fr) 2012-03-20
FR2807433A1 (fr) 2001-10-12
MXPA02009856A (es) 2004-02-26
KR20020084294A (ko) 2002-11-04
ES2302727T3 (es) 2008-08-01
CN1426410A (zh) 2003-06-25
PT1268470E (pt) 2008-06-05
DE60132981D1 (de) 2008-04-10
AU2001248463B2 (en) 2006-03-16
AR041773A1 (es) 2005-06-01
US20050288315A1 (en) 2005-12-29
NO20024795L (no) 2002-12-06
KR100832047B1 (ko) 2008-05-27
US20040038957A1 (en) 2004-02-26
ATE387441T1 (de) 2008-03-15
DK1268470T3 (da) 2008-06-30
NO20024795D0 (no) 2002-10-04
JP2004521855A (ja) 2004-07-22
DE60132981T2 (de) 2009-03-19
HUP0300428A2 (hu) 2003-06-28
AU4846301A (en) 2001-10-23
OA13294A (fr) 2007-04-13
NO329526B1 (no) 2010-11-01
ZA200207851B (en) 2004-01-26
CY1108071T1 (el) 2014-02-12
FR2807433B1 (fr) 2002-09-20
CA2405076A1 (fr) 2001-10-18
MY128443A (en) 2007-02-28
AP2002002646A0 (en) 2002-12-31
US6949569B2 (en) 2005-09-27
EP1268470B1 (fr) 2008-02-27

Similar Documents

Publication Publication Date Title
MXPA02012749A (es) Moleculas semejantes a b7 y sus usos.
MXPA03001419A (es) Combinacion terapeutica de un inhibidor de la proteina de transferencia de esteres de colesterol y atorvastatina.
AU2001243553A1 (en) Microreactor
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
MXPA03003853A (es) Abastecedor de medicamentos.
MXPA03007197A (es) Moleculas de enlace terapeuticas.
AU8649401A (en) A practical, cost-effective synthesis of coq10
GB0009605D0 (en) Medicaments
EP1254140A4 (en) SAFRAMYCIN-ECTEINASCIDIN SERIES COMPOUNDS, USES AND SYNTHESIS
AU2001281176A1 (en) Snack bar
GB0002312D0 (en) Medicaments
IL175589A0 (en) Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof
AU2001243515A1 (en) Combination drug therapy
AU2002221099A1 (en) Combination drugs
AU2001259434A1 (en) Calcitonin-related molecules
AU2001289876A1 (en) Medicament containing activated antithrombin III
HK1056882A1 (en) Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof.
AU2001248463A1 (en) Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
MXPA03004202A (es) Producto celulosico entrelazado.
GB0024362D0 (en) Medicaments
AU2001267135A1 (en) Medicaments
AU2001256445A1 (en) Novel medicines based on sesquiterpene mixtures
AU2001292897A1 (en) Novel therapy
AU2001266201A1 (en) Medicaments
MXPA02012718A (es) Moleculas semejantes a b7 y sus usos.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130404